Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex–mediated acute lupus glomerulonephritis
Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) dep...
Saved in:
Published in | The Journal of experimental medicine Vol. 210; no. 11; pp. 2387 - 2401 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Rockefeller University Press
21.10.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti–mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented. |
---|---|
AbstractList | Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti–mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented. Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti-mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented.Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti-mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented. The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection in immune complex-mediated proliferative lupus nephritis. The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection in immune complex–mediated proliferative lupus nephritis. Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was generated by introgressing a C57L/J region where Cgnz1 is located to NZM2328. R27 female mice developed aGN mediated by immune complex (IC) deposition and complement activation without progression to cGN with severe proteinuria. End stage renal disease (ESRD) was not seen in R27 mice as old as 15 mo. Thus, aGN and cGN are under separate genetic control, and IC-mediated proliferative GN need not progress to cGN and ESRD. NZM2328 and R27 female mice have comparable immune and inflammatory parameters. In contrast to NZM2328, R27 mice were resistant to sheep anti–mouse GBM serum-induced nephritis, supporting the hypothesis that aGN is mediated by autoimmunity and resistance to the development of cGN is mediated by end organ resistance to damage. Thus, autoimmunity should be considered distinct from end organ damage. The Cgnz1 region has been mapped to a 1.34 MB region with 45 genes. Nine candidate genes were identified. Clinical relevance of these observations is supported by case studies. Clinical implications and the significance to human lupus and other diseases are presented. |
Author | Gaskin, Felicia Wang, Hongyang Jiang, Chao Bagavant, Harini Dai, Chao Man Fu, Shu Cathro, Helen P. Ge, Yan Sung, Sun-Sang J. Kannapell, Carol C. |
AuthorAffiliation | 1 Division of Rheumatology and Immunology and 2 Center of Immunity, Inflammation and Regenerative Medicine, Department of Medicine ; 3 Department of Microbiology, Immunology and Cancer Biology ; 4 Division of Nephrology, Department of Medicine ; 5 Department of Pharmacology ; 6 Department of Pathology ; and 7 Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908 |
AuthorAffiliation_xml | – name: 1 Division of Rheumatology and Immunology and 2 Center of Immunity, Inflammation and Regenerative Medicine, Department of Medicine ; 3 Department of Microbiology, Immunology and Cancer Biology ; 4 Division of Nephrology, Department of Medicine ; 5 Department of Pharmacology ; 6 Department of Pathology ; and 7 Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908 |
Author_xml | – sequence: 1 givenname: Yan surname: Ge fullname: Ge, Yan – sequence: 2 givenname: Chao surname: Jiang fullname: Jiang, Chao – sequence: 3 givenname: Sun-Sang J. surname: Sung fullname: Sung, Sun-Sang J. – sequence: 4 givenname: Harini surname: Bagavant fullname: Bagavant, Harini – sequence: 5 givenname: Chao surname: Dai fullname: Dai, Chao – sequence: 6 givenname: Hongyang surname: Wang fullname: Wang, Hongyang – sequence: 7 givenname: Carol C. surname: Kannapell fullname: Kannapell, Carol C. – sequence: 8 givenname: Helen P. surname: Cathro fullname: Cathro, Helen P. – sequence: 9 givenname: Felicia surname: Gaskin fullname: Gaskin, Felicia – sequence: 10 givenname: Shu surname: Man Fu fullname: Man Fu, Shu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24101379$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk1rFjEUhYNU7NvqzrVk6cKpySQzk9kI8uIXFNzoOmSSO9PUfIxJplhXgj_Bf-gvMaUfqLhwlQt5zuEc7j1CByEGQOgxJSeUCP78HPxJSygjA6P30I52nDRjx8QB2hHStg0lZDhERzmfE0I57_oH6LDltCqGcYe-75fwlWLlHDjAOoYZUsafrAlwiRNkm4sKGnCJ2CivFsBrggsIxYaljnGpTLYx4Dhj6_0Wrkz86uDLz28_PBirChis9FYAu23dMl5c9JA2V1usZ8kWmx-i-7NyGR7dvMfo4-tXH_Zvm9P3b97tX542mgtWGjOqmc29ocM8KJj4OIlOCaa5moSYDJ9Yb3g3gABmesEG3Y-8m_VQVaNWZmDH6MW177pNNZquLZJyck3Wq3Qpo7Lyz59gz-QSLyQThI-cVYOnNwYpft4gF-lt1uCcChC3LGnX0Z4T0f8HyjlnY8t4W9Env8e6y3O7pAo8uwZ0ijknmO8QSuTVDch6A_L2Bire_oVrW1SpS6qlrPu36Be4VLqh |
CitedBy_id | crossref_primary_10_1016_j_jaut_2019_05_005 crossref_primary_10_1016_j_molmed_2017_05_006 crossref_primary_10_1172_JCI142428 crossref_primary_10_1002_art_40155 crossref_primary_10_1016_j_clim_2014_06_008 crossref_primary_10_1016_j_coi_2014_10_004 crossref_primary_10_1136_ard_2022_222495 crossref_primary_10_3389_fimmu_2023_1147526 crossref_primary_10_3389_fimmu_2019_00672 crossref_primary_10_1038_nrneph_2015_33 crossref_primary_10_1038_s41590_020_0677_6 crossref_primary_10_1016_j_clim_2021_108675 crossref_primary_10_1016_j_jaut_2019_102331 crossref_primary_10_1002_art_38679 crossref_primary_10_3389_fphar_2021_806612 crossref_primary_10_1038_nrneph_2017_34 crossref_primary_10_1038_s41581_023_00786_x crossref_primary_10_1093_rheumatology_kew400 crossref_primary_10_1016_j_clim_2017_05_015 crossref_primary_10_12688_f1000research_10445_1 crossref_primary_10_1038_nrrheum_2015_159 crossref_primary_10_1016_j_clim_2014_11_003 crossref_primary_10_1038_nrrheum_2015_178 crossref_primary_10_1016_j_molmed_2018_02_003 crossref_primary_10_1084_jem_20170479 crossref_primary_10_1016_j_clim_2016_07_024 crossref_primary_10_1002_eji_202149324 crossref_primary_10_1093_ndt_gfv374 crossref_primary_10_1093_ndt_gfv396 crossref_primary_10_3904_kjim_2017_383 crossref_primary_10_1186_s12964_024_01681_z crossref_primary_10_1111_imr_12373 crossref_primary_10_1136_annrheumdis_2018_214125 crossref_primary_10_4049_jimmunol_1601565 crossref_primary_10_1016_j_clim_2024_109939 crossref_primary_10_1038_nrrheum_2016_186 |
Cites_doi | 10.1038/gene.2012.57 10.1038/sj.ki.5001988 10.1056/NEJMra071297 10.1016/1074-7613(94)90100-7 10.1016/S0065-2776(08)60342-9 10.1084/jem.20031519 10.1007/s00281-007-0097-9 10.1002/art.1780251101 10.4049/jimmunol.175.11.7185 10.4049/jimmunol.180.3.1938 10.1056/NEJMra1100359 10.1126/science.279.5353.1052 10.4049/jimmunol.177.11.8258 10.1002/eji.1830190515 10.1002/art.10887 10.1006/clim.2001.5079 10.4049/jimmunol.177.4.2671 10.1002/art.1780400928 10.1038/ng.975 10.1016/B978-0-12-394299-9.00004-7 10.4049/jimmunol.167.4.2354 10.1073/pnas.97.12.6670 10.1007/s00281-003-0121-7 10.1002/art.34380 10.1097/00005792-197711000-00004 10.3899/jrheum.080625 10.1073/pnas.98.4.1787 10.1084/jem.161.2.378 10.1126/science.1125893 10.4049/jimmunol.1003010 10.1002/acr.21664 |
ContentType | Journal Article |
Copyright | 2013 Ge et al. 2013 |
Copyright_xml | – notice: 2013 Ge et al. 2013 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 8FD FR3 H94 P64 RC3 5PM |
DOI | 10.1084/jem.20130731 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Genetics Abstracts Immunology Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Genetics of lupus glomerulonephritis progression |
EISSN | 1540-9538 |
EndPage | 2401 |
ExternalDocumentID | PMC3804943 24101379 10_1084_jem_20130731 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: R01 AR049449 – fundername: NIAMS NIH HHS grantid: R01 AR047988 – fundername: NIAID NIH HHS grantid: R01-AI079621 – fundername: NIAMS NIH HHS grantid: P50 AR045222 – fundername: NIAID NIH HHS grantid: R01 AI079621 – fundername: NIAMS NIH HHS grantid: P50-AR04522 – fundername: NIAMS NIH HHS grantid: R01-AR047988 – fundername: NIAMS NIH HHS grantid: R01-AR049449 |
GroupedDBID | --- -~X 0VX 18M 29K 2WC 36B 4.4 53G 5GY 5RE 5VS AAYXX ABOCM ABZEH ACGFO ACNCT ACPRK ADBBV AENEX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C45 CITATION CS3 D-I DIK DU5 E3Z EBS EJD EMB F5P F9R GX1 H13 HYE IH2 K-O KQ8 L7B N9A O5R O5S OK1 P2P P6G R.V RHI SJN TR2 TRP UHB W8F WOQ CGR CUY CVF ECM EIF NPM 7X8 7T5 8FD FR3 H94 P64 RC3 5PM |
ID | FETCH-LOGICAL-c483t-d9af3f6d17f7aeb49b85a83c4ab88bd4b36d457e8e3d6837c6945fc7af39cad73 |
ISSN | 0022-1007 1540-9538 |
IngestDate | Thu Aug 21 14:37:25 EDT 2025 Fri Jul 11 15:57:24 EDT 2025 Fri Jul 11 12:37:22 EDT 2025 Mon Jul 21 05:20:25 EDT 2025 Thu Apr 24 23:11:04 EDT 2025 Tue Jul 01 03:30:38 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/). |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c483t-d9af3f6d17f7aeb49b85a83c4ab88bd4b36d457e8e3d6837c6945fc7af39cad73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 C. Jiang’s present address is Molecular Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20814. Y. Ge’s present address is Genetics Institute, University of Florida, Gainesville, FL 32610. |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3804943 |
PMID | 24101379 |
PQID | 1444392342 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3804943 proquest_miscellaneous_1551640863 proquest_miscellaneous_1444392342 pubmed_primary_24101379 crossref_primary_10_1084_jem_20130731 crossref_citationtrail_10_1084_jem_20130731 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-10-21 |
PublicationDateYYYYMMDD | 2013-10-21 |
PublicationDate_xml | – month: 10 year: 2013 text: 2013-10-21 day: 21 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of experimental medicine |
PublicationTitleAlternate | J Exp Med |
PublicationYear | 2013 |
Publisher | The Rockefeller University Press |
Publisher_xml | – name: The Rockefeller University Press |
References | Xie (2023072603061035200_bib32) 2003; 48 Rahman (2023072603061035200_bib20) 2008; 358 Tipping (2023072603061035200_bib26) 2003; 24 Morel (2023072603061035200_bib16) 2012; 115 Morel (2023072603061035200_bib17) 1994; 1 Bjorndahl (2023072603061035200_bib4) 1989; 19 Bagavant (2023072603061035200_bib2) 2006; 177 Shimizu (2023072603061035200_bib23) 2005; 175 Ward (2023072603061035200_bib28) 2009; 36 Clynes (2023072603061035200_bib5) 1998; 279 Theofilopoulos (2023072603061035200_bib25) 1985; 37 Waters (2023072603061035200_bib29) 2001; 100 Tan (2023072603061035200_bib24) 1982; 25 Hahn (2023072603061035200_bib7) 2012; 64 Kumar (2023072603061035200_bib12) 2006; 312 Al-Mayouf (2023072603061035200_bib1) 2011; 43 Lawson (2023072603061035200_bib13) 2001; 167 Bethunaickan (2023072603061035200_bib3) 2011; 186 Dooley (2023072603061035200_bib6) 2011 Morel (2023072603061035200_bib18) 2000; 97 Mahajan (2023072603061035200_bib14) 1977; 56 Mohan (2023072603061035200_bib15) 1998; 101 Xie (2023072603061035200_bib33) 2013; 14 Keppler (2023072603061035200_bib11) 2007; 71 Jacob (2023072603061035200_bib10) 2006; 177 Schiffer (2023072603061035200_bib22) 2008; 180 Waters (2023072603061035200_bib30) 2004; 199 Tsokos (2023072603061035200_bib27) 2011; 365 Holdsworth (2023072603061035200_bib9) 2007; 29 Morel (2023072603061035200_bib19) 2001; 98 Satoh (2023072603061035200_bib21) 2012; 64 Hochberg (2023072603061035200_bib8) 1997; 40 Wofsy (2023072603061035200_bib31) 1985; 161 11513551 - Clin Immunol. 2001 Sep;100(3):372-83 22129255 - N Engl J Med. 2011 Dec 1;365(22):2110-21 9461440 - Science. 1998 Feb 13;279(5353):1052-4 19004042 - J Rheumatol. 2009 Jan;36(1):63-7 9324032 - Arthritis Rheum. 1997 Sep;40(9):1725 11490025 - J Immunol. 2001 Aug 15;167(4):2354-60 18305268 - N Engl J Med. 2008 Feb 28;358(9):929-39 11172029 - Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1787-92 3890479 - Adv Immunol. 1985;37:269-390 22237992 - Arthritis Rheum. 2012 Jul;64(7):2319-27 17938927 - Semin Immunopathol. 2007 Nov;29(4):355-74 14718514 - J Exp Med. 2004 Jan 19;199(2):255-64 9502778 - J Clin Invest. 1998 Mar 15;101(6):1362-72 16778059 - Science. 2006 Jun 16;312(5780):1665-9 21411733 - J Immunol. 2011 Apr 15;186(8):4994-5003 22556106 - Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808 18209092 - J Immunol. 2008 Feb 1;180(3):1938-47 16888029 - J Immunol. 2006 Aug 15;177(4):2671-80 12778334 - Springer Semin Immunopathol. 2003 May;24(4):377-93 12687552 - Arthritis Rheum. 2003 Apr;48(4):1080-92 2544432 - Eur J Immunol. 1989 May;19(5):881-7 335188 - Medicine (Baltimore). 1977 Nov;56(6):493-501 16301622 - J Immunol. 2005 Dec 1;175(11):7185-92 3919141 - J Exp Med. 1985 Feb 1;161(2):378-91 7889410 - Immunity. 1994 Jun;1(3):219-29 17082757 - Kidney Int. 2007 Jan;71(1):74-8 17114504 - J Immunol. 2006 Dec 1;177(11):8258-65 10841565 - Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6670-5 22019780 - Nat Genet. 2011 Dec;43(12):1186-8 22608257 - Adv Immunol. 2012;115:113-39 23392277 - Genes Immun. 2013 Apr;14(3):170-8 7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7 |
References_xml | – volume: 14 start-page: 170 year: 2013 ident: 2023072603061035200_bib33 article-title: Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease publication-title: Genes Immun. doi: 10.1038/gene.2012.57 – volume: 71 start-page: 74 year: 2007 ident: 2023072603061035200_bib11 article-title: Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay publication-title: Kidney Int. doi: 10.1038/sj.ki.5001988 – volume: 358 start-page: 929 year: 2008 ident: 2023072603061035200_bib20 article-title: Systemic lupus erythematosus publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra071297 – volume: 1 start-page: 219 year: 1994 ident: 2023072603061035200_bib17 article-title: Polygenic control of susceptibility to murine systemic lupus erythematosus publication-title: Immunity. doi: 10.1016/1074-7613(94)90100-7 – volume: 37 start-page: 269 year: 1985 ident: 2023072603061035200_bib25 article-title: Murine models of systemic lupus erythematosus publication-title: Adv. Immunol. doi: 10.1016/S0065-2776(08)60342-9 – volume: 199 start-page: 255 year: 2004 ident: 2023072603061035200_bib30 article-title: Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis publication-title: J. Exp. Med. doi: 10.1084/jem.20031519 – volume: 29 start-page: 355 year: 2007 ident: 2023072603061035200_bib9 article-title: Leukocytes in glomerular injury publication-title: Semin. Immunopathol. doi: 10.1007/s00281-007-0097-9 – volume: 25 start-page: 1271 year: 1982 ident: 2023072603061035200_bib24 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum. doi: 10.1002/art.1780251101 – volume: 175 start-page: 7185 year: 2005 ident: 2023072603061035200_bib23 article-title: Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1) publication-title: J. Immunol. doi: 10.4049/jimmunol.175.11.7185 – volume: 180 start-page: 1938 year: 2008 ident: 2023072603061035200_bib22 article-title: Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis publication-title: J. Immunol. doi: 10.4049/jimmunol.180.3.1938 – volume: 365 start-page: 2110 year: 2011 ident: 2023072603061035200_bib27 article-title: Systemic lupus erythematosus publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1100359 – volume: 279 start-page: 1052 year: 1998 ident: 2023072603061035200_bib5 article-title: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis publication-title: Science. doi: 10.1126/science.279.5353.1052 – volume: 177 start-page: 8258 year: 2006 ident: 2023072603061035200_bib2 article-title: Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes publication-title: J. Immunol. doi: 10.4049/jimmunol.177.11.8258 – volume: 19 start-page: 881 year: 1989 ident: 2023072603061035200_bib4 article-title: Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies publication-title: Eur. J. Immunol. doi: 10.1002/eji.1830190515 – volume: 48 start-page: 1080 year: 2003 ident: 2023072603061035200_bib32 article-title: Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain publication-title: Arthritis Rheum. doi: 10.1002/art.10887 – volume: 100 start-page: 372 year: 2001 ident: 2023072603061035200_bib29 article-title: NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci publication-title: Clin. Immunol. doi: 10.1006/clim.2001.5079 – volume: 177 start-page: 2671 year: 2006 ident: 2023072603061035200_bib10 article-title: Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF publication-title: J. Immunol. doi: 10.4049/jimmunol.177.4.2671 – volume: 40 start-page: 1725 year: 1997 ident: 2023072603061035200_bib8 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum. doi: 10.1002/art.1780400928 – volume: 43 start-page: 1186 year: 2011 ident: 2023072603061035200_bib1 article-title: Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus publication-title: Nat. Genet. doi: 10.1038/ng.975 – volume: 115 start-page: 113 year: 2012 ident: 2023072603061035200_bib16 article-title: Mapping lupus susceptibility genes in the NZM2410 mouse model publication-title: Adv. Immunol. doi: 10.1016/B978-0-12-394299-9.00004-7 – volume: 167 start-page: 2354 year: 2001 ident: 2023072603061035200_bib13 article-title: The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus publication-title: J. Immunol. doi: 10.4049/jimmunol.167.4.2354 – volume: 101 start-page: 1362 year: 1998 ident: 2023072603061035200_bib15 article-title: Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes publication-title: J. Clin. Invest. – volume: 97 start-page: 6670 year: 2000 ident: 2023072603061035200_bib18 article-title: Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.97.12.6670 – start-page: 1 volume-title: Lupus Nephritis. year: 2011 ident: 2023072603061035200_bib6 article-title: Clinical manifestations of lupus nephritis – volume: 24 start-page: 377 year: 2003 ident: 2023072603061035200_bib26 article-title: T cells in glomerulonephritis publication-title: Springer Semin. Immunopathol. doi: 10.1007/s00281-003-0121-7 – volume: 64 start-page: 2319 year: 2012 ident: 2023072603061035200_bib21 article-title: Prevalence and sociodemographic correlates of antinuclear antibodies in the United States publication-title: Arthritis Rheum. doi: 10.1002/art.34380 – volume: 56 start-page: 493 year: 1977 ident: 2023072603061035200_bib14 article-title: Lupus nephropathy without clinical renal involvement publication-title: Medicine (Baltimore). doi: 10.1097/00005792-197711000-00004 – volume: 36 start-page: 63 year: 2009 ident: 2023072603061035200_bib28 article-title: Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004 publication-title: J. Rheumatol. doi: 10.3899/jrheum.080625 – volume: 98 start-page: 1787 year: 2001 ident: 2023072603061035200_bib19 article-title: The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.98.4.1787 – volume: 161 start-page: 378 year: 1985 ident: 2023072603061035200_bib31 article-title: Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4 publication-title: J. Exp. Med. doi: 10.1084/jem.161.2.378 – volume: 312 start-page: 1665 year: 2006 ident: 2023072603061035200_bib12 article-title: Regulation of B cell tolerance by the lupus susceptibility gene Ly108 publication-title: Science. doi: 10.1126/science.1125893 – volume: 186 start-page: 4994 year: 2011 ident: 2023072603061035200_bib3 article-title: A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis publication-title: J. Immunol. doi: 10.4049/jimmunol.1003010 – volume: 64 start-page: 797 year: 2012 ident: 2023072603061035200_bib7 article-title: American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis publication-title: Arthritis Care Res. (Hoboken). doi: 10.1002/acr.21664 – reference: 3919141 - J Exp Med. 1985 Feb 1;161(2):378-91 – reference: 14718514 - J Exp Med. 2004 Jan 19;199(2):255-64 – reference: 22129255 - N Engl J Med. 2011 Dec 1;365(22):2110-21 – reference: 22608257 - Adv Immunol. 2012;115:113-39 – reference: 10841565 - Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6670-5 – reference: 9502778 - J Clin Invest. 1998 Mar 15;101(6):1362-72 – reference: 11513551 - Clin Immunol. 2001 Sep;100(3):372-83 – reference: 17082757 - Kidney Int. 2007 Jan;71(1):74-8 – reference: 23392277 - Genes Immun. 2013 Apr;14(3):170-8 – reference: 16778059 - Science. 2006 Jun 16;312(5780):1665-9 – reference: 22237992 - Arthritis Rheum. 2012 Jul;64(7):2319-27 – reference: 11490025 - J Immunol. 2001 Aug 15;167(4):2354-60 – reference: 12778334 - Springer Semin Immunopathol. 2003 May;24(4):377-93 – reference: 7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7 – reference: 22019780 - Nat Genet. 2011 Dec;43(12):1186-8 – reference: 7889410 - Immunity. 1994 Jun;1(3):219-29 – reference: 18209092 - J Immunol. 2008 Feb 1;180(3):1938-47 – reference: 3890479 - Adv Immunol. 1985;37:269-390 – reference: 22556106 - Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808 – reference: 2544432 - Eur J Immunol. 1989 May;19(5):881-7 – reference: 335188 - Medicine (Baltimore). 1977 Nov;56(6):493-501 – reference: 11172029 - Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1787-92 – reference: 9324032 - Arthritis Rheum. 1997 Sep;40(9):1725 – reference: 19004042 - J Rheumatol. 2009 Jan;36(1):63-7 – reference: 17938927 - Semin Immunopathol. 2007 Nov;29(4):355-74 – reference: 12687552 - Arthritis Rheum. 2003 Apr;48(4):1080-92 – reference: 16301622 - J Immunol. 2005 Dec 1;175(11):7185-92 – reference: 16888029 - J Immunol. 2006 Aug 15;177(4):2671-80 – reference: 9461440 - Science. 1998 Feb 13;279(5353):1052-4 – reference: 18305268 - N Engl J Med. 2008 Feb 28;358(9):929-39 – reference: 17114504 - J Immunol. 2006 Dec 1;177(11):8258-65 – reference: 21411733 - J Immunol. 2011 Apr 15;186(8):4994-5003 |
SSID | ssj0014456 |
Score | 2.3085537 |
Snippet | Cgnz1 and Agnz1 on the distal region of mouse chromosome 1 are associated with chronic glomerulonephritis (cGN) and acute GN (aGN). NZM2328.Lc1R27 (R27) was... The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection... The mechanisms regulating acute and chronic glomerulonephritis are dependent on different genetic mechanisms, where the Cgnz1 allele confers kidney protection... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2387 |
SubjectTerms | Acute Disease Alleles Animals Antigen-Antibody Complex - adverse effects Autoantibodies - adverse effects Capillaries - pathology Capillaries - ultrastructure Chromosomes, Mammalian - genetics Dendritic Cells - metabolism Dendritic Cells - pathology Disease Progression Disease Susceptibility Endocytosis Endothelial Cells - pathology Endothelial Cells - ultrastructure Female Gene Expression Regulation Humans Immunity - immunology Inflammation - immunology Inflammation - pathology Kidney - blood supply Kidney - immunology Kidney - pathology Kidney - ultrastructure Lupus Nephritis - immunology Lupus Nephritis - pathology Macrophages - metabolism Macrophages - pathology Mice Mice, Inbred Strains Proteins - metabolism Proteinuria - metabolism Proteinuria - pathology Sheep Vacuoles - pathology Vacuoles - ultrastructure |
Title | Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex–mediated acute lupus glomerulonephritis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24101379 https://www.proquest.com/docview/1444392342 https://www.proquest.com/docview/1551640863 https://pubmed.ncbi.nlm.nih.gov/PMC3804943 |
Volume | 210 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFB7qCuKLeLfeGEGfStYmM01mHqWopVAR3YX6VCbJTLdsm5RuA7JPgj_Bf6h_xHMmk0u3q-hCCSWZdNqeL-cy5ztnCHlpjPGFMtoDcyI9iDe4FxuZelJJBa_Ij-02nZMP4eiYj6eDaafzq8VaKrbxYXJ-aV3JVaQK50CuWCX7H5KtPxROwHuQLxxBwnD8JxkP59m538PdUJaWdG6wGvd0kWbwoEMYja4hPrfgXqZqheSctWvYZCvQ83nJgbUO4wLrRHTJMNdfKwoEs4Ul6JSqBAkFy2JdnGETkZXeFMs80wAFbIrUdnGbYjPr5u5sIXAxk__eLqd-aRA6Xrj16-GJypuElVvTLjLvM1zvjQ-bBdi5gljAWpKRwmxUexnDt4S4oFnGwO_2CSyANpiv2OzVSbZ1OITPyO0oLZhT27yPiWjR1uuB48s6APttNc2clS9NPng1_qXmpC84mhONLQt81IY7wwAM65WFFrhB2LpRNka1pjp-nAyZwCY87Bq5HkAsYyvSpzUPCQJau8Vw_bNcdQZM_bo9MXatdrPsulB7cdFFem_LXzq6TW45BNA3JWrvkI7O7pIbEweAe-S7BS8twUsdeGkJXtqAl25zWoKXNuClLfDS3NASvNSB9-e3HxVsqYUttbCl-7C9T47fvT0ajjy3I4iXcMG2XiqVYSZM_chESsdcxmKgBEu4ioWIUx6zMOWDSAvN0lCwKAklH5gkgrtkotKIPSAHGczyiNDQmDTuC21k7HOTSKV1YKKBCsRASwg7uqRX_cmzxLXLx11bljNL2xB8BtKZVdLpklf16HXZJuYP415U8pqBHsfknMp0XpxBCM4hNggYD_4yBrPavC9C1iUPSxnXs1Xg6JJoR_r1AOwjv3slW5zYfvIOn4-vfOcTcrN5pJ-Sg-2m0M_AV9_Gzy3WfwOWXfWt |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cgnz1+allele+confers+kidney+resistance+to+damage+preventing+progression+of+immune+complex%E2%80%93mediated+acute+lupus+glomerulonephritis&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Ge%2C+Yan&rft.au=Jiang%2C+Chao&rft.au=Sung%2C+Sun-Sang+J.&rft.au=Bagavant%2C+Harini&rft.date=2013-10-21&rft.pub=The+Rockefeller+University+Press&rft.issn=0022-1007&rft.eissn=1540-9538&rft.volume=210&rft.issue=11&rft.spage=2387&rft.epage=2401&rft_id=info:doi/10.1084%2Fjem.20130731&rft_id=info%3Apmid%2F24101379&rft.externalDocID=PMC3804943 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon |